1. Home
  2. ICHR vs CDNA Comparison

ICHR vs CDNA Comparison

Compare ICHR & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$41.43

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$17.01

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
CDNA
Founded
1999
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.0B
IPO Year
2016
2007

Fundamental Metrics

Financial Performance
Metric
ICHR
CDNA
Price
$41.43
$17.01
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$40.67
$27.33
AVG Volume (30 Days)
791.9K
539.5K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$947,652,000.00
$48,324,000.00
Revenue This Year
$18.08
$15.37
Revenue Next Year
$12.06
$11.23
P/E Ratio
N/A
N/A
Revenue Growth
11.61
18.93
52 Week Low
$13.15
$10.96
52 Week High
$55.00
$21.49

Technical Indicators

Market Signals
Indicator
ICHR
CDNA
Relative Strength Index (RSI) 49.00 37.34
Support Level $15.70 $16.74
Resistance Level $55.00 $17.09
Average True Range (ATR) 3.51 0.83
MACD -1.40 -0.21
Stochastic Oscillator 17.79 23.77

Price Performance

Historical Comparison
ICHR
CDNA

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: